Fuad F. Elkhoury, MD
Accepting new patients

Fuad F. Elkhoury, MD

  • Endourology and Stone Disease|
  • Urology
Santa Monica Urology | 1260 15th Street, Suite 1200, Santa Monica, CA 90404
310-794-7700

About

Dr Fuad F. Elkhoury is an Assistant Clinical Professor of Urology at UCLA. He completed his urology residency at the UCLA Department of Urology and completed his fellowship in endourology and robotic surgery at UCLA. He is an expert in the surgical management of benign prostatic hyperplasia (BPH) for men suffering from lower urinary tract symptoms and is an expert in Holmium Laser Enucleation of the Prostate (HoLEP). Dr Elkhoury also specializes in the surgical and medical management of kidney stones and is a leading kidney stone surgeon in Southern California. He also cares for patients with all urologic conditions and performs the full spectrum of urologic procedures. He has a special interest in optimizing surgical outcomes in men with benign prostatic hyperplasia and kidney stones and developing novel minimally invasive approaches to treat urologic conditions.

Languages

English

Education

Medical Board Certification

Urology, American Board of Urology, 2023

Fellowship

Endourology, UCLA School of Medicine, 2021

Residency

Urology, UCLA School of Medicine, 2020

Internship

Surgery, UCLA School of Medicine, 2015

Degree

MD, UCSD School of Medicine, 2014

Recognitions

  • SuperDoctors 2024 - Rising Stars Award
  • Willard E. Goodwin MD Resident Teaching Award – Department of Urology, University of California, Los Angeles, 2020
  • Administrative and Education Chief Resident – Department of Urology, University of California, Los Angeles, 2019-2020.
  • See More

Locations

Hospital Affiliations

Ronald Reagan UCLA Medical Center

UCLA Santa Monica Medical Center

Research

Publications

  1. Elkhoury, FF, Felker ER, Kwan L, Sisk AE, Delfin M, Natarajan S, Marks LS. Comparison of Targeted vs Systematic Biopsy in Men who are Biopsy Naïve: The Prospective Assessment of Image Registration in the Diagnosis of Prostate Cancer (PAIREDCAP) Study. JAMA Surg. 2019 Sept; 154(9): 811-818.
  2. Elkhoury FF: Editorial Comment: Does "My Chart" Benefit My Surgery? A Look at the Impact of Electronic Patient Portals on Patient Experience. Journal of Urology. July 2020.
  3. Salami SS, Tosoian JJ, Nallandhighal S, Jones TA Jr, Brockman S, Elkhoury FF, Bazzi S, Plouffe KR, Siddiqui J, Liu CJ, Kunju LP, Morgan TM, Natarajan S, Boonstra PS, Sumida L, Tomlins SA, Udager AM, Sisk AE Jr, Marks LS, Palapattu GS. Serial Molecular Profiling of Low-Grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. European Urology. July 2020.
  4. Felker ER, Raman SS, Lu DSK, Tuttle M, Margolis DJ, Elkhoury FF, Sayre J, Marks LS. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer after Focal Laser Ablation. American Journal of Roentgenology. 2019 Dec; 213(6) 1253-1258.
  5. Felker ER, Raman SS, Shakeri S, Mirak SA, Bajgiran AM, Kwan L, Elkhoury FF, Margolis DJA, Karow D, Lu DSK, White N, Marks LSM. Utility of Restriction Spectrum Imaging Among Men Undergoing First-time Biopsy for Suspected Prostate Cancer. American Journal of Roentgenology. 2019 August; 213(2); 365-370.
  6. Elkhoury, FF, Simopoulos DN, Marks LS. MR-Guided Biopsy and Focal Therapy: New Options for Prostate Cancer Management. Current Opinions Urology. 2018 March; 28(2): 93-101.
  7. Elkhoury FF, Rambhalta A, Mills JN, Rajfer J. Cardiovascular Health, Erectile Dysfunction, and Testosterone Replacement: Controversies and Correlations. Urology. 2017 Dec. 110:1-8.
  8. Elkhoury FF, Simopoulos DN, Marks LS. Targeted Biopsy in the Era of Active Surveillance. Urology. 2018 Feb; 112:12-19.
  9. Abbot JE, Miller DL, Shi W, Wenzler D, Elkhoury FF, Patel ND, Sur RL. Optimization of urinary dipstick pH: Are multiple dipstick pH readings reliably comparable to commercial 24-hour urinary pH? Investig Clin Urol. 2017 May; 58: e62.
  10. Mirheydar HS, Raheem OA, Elkhoury FF, Jabaji R, Palazzi KL, Patel N, Sakamoto K. Modern advances in reducing anxiety and pain associated with cystoscopy: Systematic Review. World J Transl Med. 2015 April 12; 4; 38-43.

Insurance

  • Aetna
  • Anthem Blue Cross
  • Blue Shield of California
  • Centivo
  • Cigna
  • First Health
  • Health Net of California
  • Interplan (part of HealthSmart)
  • L.A. Care
  • Medicare Advantage
  • MultiPlan
  • UFCM Health System
  • Prime Health Services
  • Private Healthcare Systems (PHCS)
  • TRICARE
  • UnitedHealthcare

The list of health care plans above may not be comprehensive and could change. 
Please contact your benefits coordinator or health insurance company directly to verify coverage.

Visit our health insurance information page for more details.

Recognitions

  • SuperDoctors 2024 - Rising Stars Award
  • Willard E. Goodwin MD Resident Teaching Award – Department of Urology, University of California, Los Angeles, 2020
  • Administrative and Education Chief Resident – Department of Urology, University of California, Los Angeles, 2019-2020.
  • Guy Dalla Riva Award for Excellence in Clinical Care and Research – Department of Urology, University of California, Los Angeles, 2019
  • H&H Lee Research Grant – University of California, Los Angeles, 2017
  • CI-CARE Award for Exceptional Patient-Centered Care – University of California, Los Angeles, 2016
  • National Institute of Health Research Training Grant – University of California, San Diego School of Medicine, 2012
  • Phi Beta Kappa Honors Society – University of California, Los Angeles, 2010
  • Summa Cum Laude Honors -- University of California, Los Angeles, 2010
  • UCLA Departmental Honors for Senior Thesis in Molecular, Cell and Developmental Biology, 2010
  • UCLA Distinguished Senior Award, 2010